About Us

We are on a mission to re-write the rules of drug discovery.

“At Cellarity, we are focused on the entire cell state – not just a single disease target. I believe that will lead to much better treatments.”

Max Rogers-Grazado, Scientist

Meet The Team

Our Leadership Team

With our combined expertise in drug development, artificial intelligence and machine learning, computational biology, biology and chemistry, we are developing game-changing medicines that holistically correct disease biology to improve outcomes for people with a range of challenging diseases.

A critical element of our success is our collaborative culture, which fosters innovation and cross-discipline cooperation among seasoned experts in artificial intelligence and machine learning, biology, computational biology and chemistry.

Our Founders

We are founded by a visionary team on a mission to push the boundaries of drug discovery in service of patients. Hailing from both Flagship Pioneering and academia, our roots lie in asking “What if…?” and finding the answers.

Our Board

Our Board includes industry leading experts from the pharma, biotech and tech industries. Energized by our mission to create medicines currently out of reach to patients in need, our Board embraces our passion for harnessing the power of AI and single-cell omics data to see disease biology others can’t.

Team Categories

Reset

Alec_Reynolds_Cellarity

Alec Reynolds

Chairman, Cellarity; Senior Partner, Flagship Pioneering

Ted_Myles_BOD

Ted Myles

Director and CEO, Cellarity

Cellarity_Ted_CEO

Ted Myles

Director and CEO, Cellarity

John Leaman@2x

John Leaman

Chief Financial Officer

Cameron Trenor@2x

Cameron Trenor

Chief Medical Officer

Atli Thorarensen@2x

Atli Thorarensen

Chief Scientific Officer

Parul Doshi@2x

Parul Doshi

Chief Data Officer

Rushmie

Rushmie Nofsinger

Chief Corporate Affairs Officer

Rajiv Amin@2x

Rajiv Amin

Head of Finance, Corporate Controller

Cellarity-Olivier

Olivier Bezy

Head of Biology

Govinda Bhisetti@2x

Govinda Bhisetti

Head of Computational Chemistry

Cellarity-Mauricio

Mauricio Cortes

Head of Discovery Science

Na Li

VP, DMPK

Cellarity team placeholder

Robb Nicewonger

Distinguished Fellow, Medicinal Chemistry

Screenshot 2024-11-18 at 9.05.40 AM

Erik Spek

VP, Head of Legal and IP

Portrait_Sophie (1)

Sophie Tritschler

Senior Director, Computational Biology

Mahdi_Headshot

Mahdi Zamanighomi

Senior Director, Machine Learning

Avak Kahvejian@2x

Avak Kahvejian

Founding CEO and Director, Cellarity; General Partner, Flagship Pioneering

Jim Collins@2x

Jim Collins

Academic Co-Founder and Director, Cellarity; Termeer Professor, MIT; Broad Institute; Wyss Institute; Harvard

Nick Plugis@2x

Nick Plugis

Co-Founder, Cellarity; Senior Principal, Flagship Pioneering

Noubar Afeyan@2x

Noubar Afeyan

Co-Founder, Cellarity; Founder & CEO, Flagship Pioneering

Ian Estepan@2x

Ian Estepan

Director, Cellarity; EVP and CFP, Sarepta Therapeutics

Sandra Horning@2x

Sandra Horning

Director, Cellarity; Former EVP, CMO and Head of Global Product Development, Roche/Genentech

Stephen Berenson@2x

Stephen Berenson

Director, Cellarity; Advisor Partner, Flagship Pioneering

Percy Carter

Director, Cellarity; Chief Scientific Officer, Blueprint Medicines

Gregory Moore@2x

Gregory Moore

Director, Cellarity; Senior Advisor, Gates Ventures

Cellarity was founded on the premise that traditional drug discovery is limited by human bias. Conventional drug discovery narrows down disease to a single target to define and deliver therapeutic interventions, but often this approach is insufficient because disease phenotypes are based on a cascade of complex cellular relationships and interactions that occur at specific times in the cell development process. Focusing on therapeutic intervention within this dynamic disease state, Cellarity’s goal is to deliver novel therapeutics that switch disease mechanisms to healthy cell function.

At Cellarity, we believe we can vastly improve outcomes by designing therapeutics that correct cell-state dysfunction. Our integrated multi-omics and AI-powered discovery platform comprehensively maps networks of cell and gene interactions to predict and design oral Cell State-Correcting therapeutics that can precisely regulate gene “switch” mechanisms to restore proper cell function. Cellarity was launched by Flagship Pioneering in 2019.